EDBI is a Singapore-based venture capital firm that makes investments in growth-stage technology companies.
Business Model:
Revenue: $23M
Employees: 51-200
Address: 250 North Bridge Road
City: Singapore
State: central singapore
Zip: 179101
Country: SG
EDBI is a Singapore-based venture capital firm that makes investments in growth-stage technology companies.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2019 | M-DAQ | Series D | - |
6/2011 | Smaato | Series D | 3M |
7/2016 | Sprinklr | Series F | 105M |
11/2009 | Standard BioTools | Venture Round | 0 |
8/2017 | Appier | Series C | 33M |
1/2007 | Standard BioTools | Series E | 0 |
8/2020 | Rigetti Computing | Series C | 0 |
8/2016 | LogRhythm | Venture Round | 50M |
1/2004 | Standard BioTools | Series D | 21M |
6/2019 | Circles.Life | Venture Round | - |
12/2005 | Amaranth Medical | Seed Round | - |
4/2022 | RVAC Medicines | Series B | 140M |
8/2013 | Ivantis | Series B | 5M |
6/2018 | Puppet | Series F | 42M |
2/2022 | Beam | Series B | 0 |
9/2012 | RAMP Holdings | Series C | 15M |
12/2022 | Doctor Anywhere | Series C | 0 |
5/2021 | Engine Biosciences | Series A | 0 |
12/2012 | goBalto | Series B | 0 |
11/2018 | Ambiq Micro | Series E | 28M |
7/2021 | AvePoint | Post-IPO Equity | 140M |
11/2018 | WalkMe | Series F | 10M |
12/2009 | FORMA Therapeutics | Series B | 25.5M |
4/2011 | Crisp Mobile | Series C | 6M |
2/2019 | Zilingo | Series D | 226M |
5/2004 | Microbia | Series D | 40M |
6/2014 | Declara | Series A | 0 |
1/2018 | Engine Biosciences | Seed Round | 10M |
1/2011 | Smaato | Series C | 7M |
12/2007 | Pelikan Technologies | Series F | 69M |
4/2022 | Neuron Mobility | Series B | 0 |
4/2020 | Screening Eagle Technologies | Series A | 56.4M |
9/2021 | Neuroglee Therapeutics | Series A | 10M |
12/2011 | Sotera Wireless | Series D | 12.2M |
12/2021 | Sleek | Series A | 11M |
5/2010 | Coda Automotive | Series C | 58M |
4/2014 | Sotera Wireless | Venture Round | 0 |
6/2021 | Nuevocor | Series A | 0 |
11/2019 | SWAT Mobility | Series A | 10.1M |
8/2020 | Vesta | Venture Round | - |
7/2021 | MiRXES | Series C | 0 |
5/2004 | Addex Therapeutics | Series B | 0 |
6/2022 | DataStax | Private Equity Round | 0 |
1/2019 | Pear Therapeutics | Series C | 64M |
9/2016 | Shape Security | Series D | 40M |
4/2022 | Voyager Innovations | Convertible Note | 0 |
11/2021 | Endowus | Venture Round | 25.6M |
4/2022 | Biofourmis | Series D | 0 |
5/2018 | Carousell | Series C | 85M |
3/2020 | ShopBack | Series B | 30M |
9/2015 | Paxata | Series C | 0 |
5/2011 | Silecs | Series E | 0 |
11/2017 | MetricStream | Private Equity Round | 65M |
9/2011 | Tremor Video | Venture Round | 0 |
12/2009 | Revance Therapeutics | Series D | 0 |
7/2010 | Artisan Pharma | Series C | 0 |
11/2016 | GoSecure | Series C | 0 |
7/2020 | Transcelestial Technologies | Series A | 9.6M |
9/2014 | Taulia | Series D | 0 |
12/2020 | Pear Therapeutics | Series D | 0 |
10/2010 | TriReme Medical | Series D | 17M |
3/2017 | Hedvig | Series C | 21.5M |
7/2021 | SCI Ecommerce | Venture Round | 0 |
6/2018 | Bitmain | Series B | 292.7M |
5/2019 | Biofourmis | Series B | 0 |
3/2019 | Carro | Series B | 0 |
8/2006 | Codexis | Series D | 0 |
2/2016 | Knewton | Series F | 0 |
9/2006 | Artisan Pharma | Series A | 39M |
8/2019 | Inari | Series C | 89M |
9/2022 | ImmunoScape | Venture Round | 14M |
4/2021 | ImmunoSCAPE | Venture Round | 14M |
7/2021 | Nature’s Fynd | Series C | 0 |
2/2022 | Modalku | Series C | 0 |
2/2022 | Funding Societies | Series C | 0 |
9/2021 | Advance Intelligence Group | Series D | 400M |
4/2022 | Us2.ai | Series A | 15M |
4/2021 | Cityneon | Private Equity Round | 176.9M |
11/2019 | Cityneon | Private Equity Round | - |
9/2020 | Seismic | Series F | 92M |
4/2020 | Erasca | Series B | 0 |
2/2022 | Next Gen Foods | Series A | 0 |
10/2002 | MerLion Pharma | Series A | 0 |
1/2003 | Raven Biotechnologies | Series C | 0 |
3/2010 | Artisan Pharma | Series B | 22M |
3/2020 | ElevateBio | Series B | 170M |
3/2014 | goBalto | Venture Round | 0 |
12/2020 | GaiaWorks | Series D | 0 |
8/2020 | Aetion | Series B | 19M |
2/2004 | Kadmus Pharmaceuticals | Series A | 0 |
1/2016 | Savioke | Series A | 15M |
10/2010 | MerLion Pharma | Series C | 0 |
8/2017 | iflix | Series C | 0 |
10/2017 | Magic Leap | Series D | 502M |
10/2011 | Contour Energy | Series C | 20M |
1/2022 | Hazel Technologies | Venture Round | - |
10/2017 | KLOOK | Series C | 60M |
10/2021 | H3 Dynamics | Series B | 26M |
10/2009 | Inviragen | Series A | 0 |
10/2022 | Structo | Venture Round | 0 |
6/2021 | wefox | Series C | 650M |
1/2015 | goBalto | Series C | 0 |
3/2020 | Doctor Anywhere | Series B | 27M |
1/2010 | Innovalight | Series D | 0 |
3/2019 | CXA Group | Series C | 0 |
2/2021 | vArmour | Venture Round | 0 |
12/2017 | Tessa Therapeutics | Private Equity Round | 80M |
1/2020 | Livspace | Series D | 0 |
2/2022 | MiRXES | Series C | 0 |
4/2011 | Mblox | Venture Round | - |
9/2006 | Addex Therapeutics | Series C | 0 |
10/2019 | Structo | Series D | - |
12/2021 | Ember Technologies | Series E | 23.5M |
10/2009 | ScanScout | Series B | 8.5M |
12/2020 | Pico | Series C | 0 |
8/2014 | Smaato | Series E | 25M |
6/2018 | I-Mab Biopharma | Series C | 0 |
9/2018 | Moka | Series B | 24M |
6/2022 | Tessa Therapeutics | Series A | 0 |
8/2014 | Appcelerator | Series D | 22M |
6/2011 | Vivotech | Series C | 24M |
9/2022 | Fazz | Series C | 75M |
7/2022 | wefox | Series D | 400M |
10/2013 | Amaranth Medical | Series B | 0 |
4/2022 | UPSIDE Foods | Series C | 0 |
1/2018 | Pear Therapeutics | Series B | 50M |
1/2020 | eko.ai | Equity | 4M |
10/2007 | Vobile | Series B | 10.2M |
12/2021 | Bolttech | Series A | 37.2M |
6/2011 | Mblox | Venture Round | 13.8M |
7/2021 | VNLIFE | Series B | 250M |
10/2016 | Paxata | Series D | 33.5M |
10/2019 | Nuvation Bio | Series A | 275M |
10/2022 | Resolve BioSciences | Series B | 71M |
9/2006 | RenaMed Biologics | Venture Round | 0 |
2/2017 | Lytro | Series D | 60M |
10/2021 | ShopBack | Series E | 40M |
10/2015 | Coursera | Series C | 0 |
12/2009 | FORMA Therapeutics | Series B | 3M |
3/2021 | ElevateBio | Series C | 525M |
5/2023 | ElevateBio | Series D | 0 |
9/2016 | Druva | Series E | 51M |
1/2016 | Greenwave Systems | Series C | 45M |
5/2022 | Aspen Neuroscience | Series B | 0 |
7/2013 | Appcelerator | Unattributed | 12.1M |
9/2020 | Biofourmis | Series C | 100M |
4/2018 | Rotimatic | Series C | 30M |
9/2011 | Tremor Video - Software Platform | Venture Round | 0 |
2/2018 | Joby Aviation | Series B | 100M |
6/2015 | GoSecure | Series C | 0 |
1/2014 | Ivantis | Series B | 14M |
3/2017 | Livongo | Series D | 0 |
5/2021 | Esco Lifesciences | Series A | 0 |
5/2021 | Hummingbird Bioscience | Series C | 0 |
2/2017 | CXA Group | Series B | 25M |
12/2018 | Pindrop | Series D | 90M |
1/2020 | eko.ai | Funding Round | 4M |
4/2019 | ShopBack | Series B | 45M |
10/2008 | S*Bio | Venture Round | 26M |
9/2018 | OakNorth | Series B | 0 |
9/2006 | Amaranth Medical | Series A | 7.5M |
2/2018 | Moderna Therapeutics | Series G | 0 |
6/2022 | DataStax | Private Equity Round | 0 |
6/2022 | Tessa Therapeutics | Series A | 0 |
5/2022 | Aspen Neuroscience | Series B | 0 |
4/2022 | Neuron Mobility | Series B | 0 |
4/2022 | RVAC Medicines | Series B | 0 |
4/2022 | Biofourmis | Series D | 0 |
4/2022 | UPSIDE Foods | Series C | 0 |
4/2022 | Us2.ai | Series A | 0 |
4/2022 | Voyager Innovations | Convertible Note | 0 |
2/2022 | Beam | Series B | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|